Daniel Einhorn, MD
Enriched profileVice President, Endocrine Strategy · Corcept Therapeutics
Daniel Einhorn is Vice President, Endocrine Strategy at Corcept Therapeutics. ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Daniel Einhorn, MD, is Vice President, Endocrine Strategy at Corcept Therapeutics. The public record shows 101 publications with 15,520 citations (h-index 39), centered on Type 2 Diabetes. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 16 companies.
- Top research focus: Type 2 Diabetes
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20251 payment
- Corcept TherapeuticsProgram year20251 payment
- Novo Nordisk IncProgram year20251 payment
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
50.2%Biguanide (metformin)16.3%Metformin Hcl Er51%Metformin Hcl49%Part D≥41 patientsSGLT2 inhibitor13.6%Jardiance75%Farxiga14%Invokana10%Part D<11 patientsHormonal (systemic)
34.7%l-Thyroxine34.7%Levothyroxine Sodium57%Synthroid43%Part D≥80 patientsCardiovascular
15.1%Statin15.1%Atorvastatin Calcium73%Rosuvastatin Calcium28%Part D≥43 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/daniel-einhorn-56b5538b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Daniel-Einhorn
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/corcept-therapeutics_dan-einhorn-spent-the-past-30-years-caring-activity-6926914775436169216-QqvD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
tcoydthepodcast.transistor.fm/57
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tcoydthepodcast.transistor.fm ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Tufts University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - BA
Yale University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →yelp.com ↗ - Board Certified
Endocrinology, Diabetes & Metabolism (taxonomy 207RE0101X); Internal Medicine fellowship/residency, Harvard Medical School / Beth Israel Deaconess Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →npidb.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pro.aace.com ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Journal of Diabetes (Wiley)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onlinelibrary.wiley.com ↗ - Past President
American Association of Clinical Endocrinologists (AACE)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.corcept.com ↗ - Past President
American College of Endocrinology (ACE)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.corcept.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org ↗
- ACE Yank D. Coble Jr.
M.D., Distinguished Service Award (American College of Endocrinology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗ - ACE Foundation John A. Seibel
M.D., Award
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗
Secondary affiliations
appointments beyond the home institution- President
Diabetes and Endocrine Associates (La Jolla/Poway/La Mesa, CA private practice)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com ↗ - Medical Director
Scripps Whittier Diabetes Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Clinical Professor of Medicine
University of California, San Diego (UCSD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Media & interviews
press, podcasts and appearances- Podcast guest
"Taking Control Of Your Diabetes" (TCOYD), episode on hypercortisolism and difficult-to-control diabetes
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tcoydthepodcast.transistor.fm ↗ - Podcast guest
Consultant360, "Daniel Einhorn, MD, on Treating CVD in Diabetes"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultant360.com ↗ - Video interview
Healio, "Lifestyle decisions can weigh heavily on diabetes risk"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.